Crystal Palace Face Decision on Joel Ordonez After Medical Reveals Worse-Than-Expected Injury

Crystal Palace's move for Joel Ordonez has hit a snag after his medical, leaving the Premier League club to decide whether to push the deal through or walk away.

BBC Sport reported on 28 August that Palace had hijacked Aston Villa's pursuit of the Club Brugge defender, agreeing an initial loan with an option to buy at the end of the season. The deal, reported by Goal.com to be worth around €30 million, now hangs in the balance.

The complication is Ordonez's foot. The 22-year-old Ecuador centre-back is recovering from a broken metatarsal — one of the long bones in the foot — and the injury is understood to be worse than Palace originally believed, though the club were aware of it when negotiating the deal (BBC Sport). The medical simply revealed the full picture.

Palace's urgency to sign a centre-back is easy to trace. Chadi Riad was taken off on a stretcher against Everton, accelerating Palace's search for defensive reinforcement. They have already completed a loan deal for Axel Disasi from Chelsea, but they want at least one more body at the back before the window closes.

Ordonez's journey to this point is a good one. He left Ecuador's Independiente del Valle — the famed academy that has produced a stream of South American talent — and joined Club Brugge in 2022. A season at Club NXT, Brugge's reserve side, preceded his step up to the first team permanently in 2023. He signed a contract extension running until 2028, then another last September that pushed it to 2029 (Club Brugge). Club Brugge had not entertained an earlier departure during this window, according to The Athletic, which makes Palace's late push all the more striking.

For Palace, the calculation now is straightforward but difficult. A loan with an option to buy protects them if Ordonez's recovery stalls — they are not committed to a permanent fee unless the player proves his fitness and quality. But if the medical suggests a longer road back than expected, even a loan carries risk: wages, a squad slot, and a defender who cannot contribute immediately.

The transfer window, for those less familiar, is the fixed period each season during which clubs can register new players. The summer window in England closes on 1 September, so Palace have days, not weeks, to make their call.

What makes this stand out is the chain of events that led here. Palace identified a target, beat a rival to the agreement, and then discovered the medical reality might not match their optimism. It is the kind of twist that makes deadline week compelling — a deal that looked done suddenly facing a wall.

Palace must now weigh the reward against the risk, and they do not have long to decide.